NemaLife, Inc

NemaLifes mission is to accelerate and de-risk R&D for companies in the food, nutraceutical, microbiome and pharma industries. In these industries, performing human-relevant high throughput biology and doing so with efficiency and speed has been a mutually exclusive affair. NemaLife has solved this major challenge by developing an AI-assisted microfluidics-based in vivo platform based on the microscopic worm C. elegans that has strong relevance for human biology. This 3R-compliant cruelty-free technology capable of testing a variety of compounds and their combinations is an alternative to expensive and time-consuming mouse models. We work with companies as their R&D partner, accelerating the...

Aging,disease modeling,drug discovery,transgenics,longevity,lifespan,healthspan,screening,microbiome,neurodegeneration,toxicity, in vivo assays,c. elegans,functional food ingredients,prebiotics,probiotics,postbiotics,microfluidics,and machine learning

Nemalife, inc operates in the Biotechnology research industry.

Nemalife, inc's revenue is 1m - 10m

Nemalife, inc has 11 - 50 employees.